The top story was Marilyn Tavenner became the nation's top healthcare lobbyist when she was named the new president and CEO of America's Health Insurance Plans, plus the controversial new guidelines that called for more Americans to take statins were validated, according to the results of a new study.
This week the top story was the appointment of Marilyn B. Tavenner, former administrator for CMS, as the new president and chief executive officer of America's Health Insurance Plans (AHIP). Former AHIP President Karen Ignagni left the job in May for a new position with EmblemHealth. The new role will make Ms Tavenner, who was elected unanimously by the board of directors, the nation's top healthcare lobbyist.
Last week, the House voted overwhelmingly to pass the 21st Century Cures Act, which advances Big Data, strengthens the National Institutes of Health and precision medicine, and speeds the FDA approval process. The act promotes research in diseases that range from cancer, to multiple sclerosis, to ALS.
A new study in JAMA has validated the 2013 statin guidelines that caused much controversy when the American Heart Association and the American College of College of Cardiology issued them. The guidelines call for more Americans to take statins and the study found that the new guidelines are efficient and cost-effective.
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
The Biden administration recently launched the Global Health Security Strategy, a new effort to combat the spread of infectious diseases; lawmakers zeroed in on the risks of massive consolidation in health care during the first congressional hearing on the Change Healthcare hack; the FDA recently announced the recall of a pair of heart devices linked to numerous deaths and injuries.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen